C-Rad AB (LTS:0R44) Cyclically Adjusted Revenue per Share: kr9.65 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R44 C-Rad AB LTS:0R44
83 GF Score
Price kr37.90
GF Value kr34.46
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB Cyclically Adjusted Revenue per Share?

C-Rad AB LTS:0R44 83 Cyclically Adjusted Revenue per Share is kr9.65 as of Jun. 2026. GuruFocus rates LTS:0R44 with a GF Score™ of 83/100 and a GF Value™ of kr34.46 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

C-Rad AB's adjusted revenue per share for the three months ended in Jun. 2026 was kr3.601. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr9.65 for the trailing ten years ended in Jun. 2026.

During the past 12 months, C-Rad AB's average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of C-Rad AB was 23.60% per year. The lowest was 15.80% per year. And the median was 21.50% per year.

As of today (2026-07-25), C-Rad AB's current stock price is kr37.90. C-Rad AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was kr9.65. C-Rad AB's Cyclically Adjusted PS Ratio of today is 3.93.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of C-Rad AB was 16.57. The lowest was 2.63. And the median was 8.78.


C-Rad AB  (LTS:0R44) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

C-Rad AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=37.90/9.65
=3.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of C-Rad AB was 16.57. The lowest was 2.63. And the median was 8.78.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


C-Rad AB Cyclically Adjusted Revenue per Share Related Terms


C-Rad AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for C-Rad AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-Rad AB Cyclically Adjusted Revenue per Share Chart

C-Rad AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.97 5.64 7.14 8.48 8.96

C-Rad AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 9.11 8.96 9.60 9.65

LTS:0R44 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, C-Rad AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Cyclically Adjusted PS Ratio falls into.


LTS:0R44
83GF Score
C-Rad AB LTS:0R44
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C-Rad AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, C-Rad AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.601/134.1100*134.1100
=3.601

Current CPI (Jun. 2026) = 134.1100.

C-Rad AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.816 101.138 1.082
201612 0.949 102.022 1.247
201703 0.824 102.022 1.083
201706 1.048 102.752 1.368
201709 1.064 103.279 1.382
201712 1.613 103.793 2.084
201803 1.080 103.962 1.393
201806 1.622 104.875 2.074
201809 1.557 105.679 1.976
201812 1.876 105.912 2.375
201903 1.526 105.886 1.933
201906 1.661 106.742 2.087
201909 1.794 107.214 2.244
201912 1.266 107.766 1.575
202003 1.609 106.563 2.025
202006 1.332 107.498 1.662
202009 1.589 107.635 1.980
202012 1.722 108.296 2.132
202103 1.775 108.360 2.197
202106 1.790 108.928 2.204
202109 1.870 110.338 2.273
202112 2.182 112.486 2.601
202203 1.661 114.825 1.940
202206 1.855 118.384 2.101
202209 2.470 122.296 2.709
202212 2.819 126.365 2.992
202303 2.497 127.042 2.636
202306 2.680 129.407 2.777
202309 3.290 130.224 3.388
202312 4.095 131.912 4.163
202403 3.491 132.205 3.541
202406 3.828 132.716 3.868
202409 2.962 132.304 3.002
202412 3.595 132.987 3.625
202503 3.515 132.825 3.549
202506 3.112 133.699 3.122
202509 3.320 133.480 3.336
202512 3.130 133.390 3.147
202603 3.098 133.560 3.111
202606 3.601 134.110 3.601

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr9.65 mean?
C-Rad AB (LTS:0R44) has a Cyclically Adjusted Revenue per Share of kr9.65 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on C-Rad AB and its competitors.
Is C-Rad AB's Cyclically Adjusted Revenue per Share too high?
C-Rad AB's current Cyclically Adjusted Revenue per Share is kr9.65. Overall, C-Rad AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does C-Rad AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
C-Rad AB's Cyclically Adjusted Revenue per Share of kr9.65 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on C-Rad AB and its competitors. C-Rad AB's current Cyclically Adjusted Revenue per Share is kr9.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-Rad AB stock overvalued right now?
Based on GuruFocus' analysis, C-Rad AB (LTS:0R44) is currently considered Modestly Overvalued. The stock's GF Value™ is kr34.46, compared to a current price of kr37.90 — trading 10% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr9.65. C-Rad AB's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For C-Rad AB (LTS:0R44), the current Cyclically Adjusted Revenue per Share is kr9.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr37.90 is trading 10% above its estimated GF Value™ of kr34.46. GuruFocus considers C-Rad AB to be Modestly Overvalued.

Key valuation signals for LTS:0R44:

  • Cyclically Adjusted Revenue per Share: kr9.65
  • GF Value™: kr34.46 vs. price of kr37.90 (10% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
83GF Score

Get the complete analysis for LTS:0R44

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr37.90
Price
kr34.46
GF Value